Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Drbagholders Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1351507242206580736.png) @Drbagholders DrBagholder

DrBagholder posts on X about $novo, $googl, $ampx, $ntla the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1351507242206580736/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1351507242206580736/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXX +1,371%
- X Months XXXXXX +23%
- X Year XXXXXX +1,874%

### Mentions: X [#](/creator/twitter::1351507242206580736/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1351507242206580736/c:line/m:posts_active.svg)

- X Week X +14%
- X Month XX +250%
- X Months XX +71%
- X Year XX +529%

### Followers: XXX [#](/creator/twitter::1351507242206580736/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1351507242206580736/c:line/m:followers.svg)

- X Week XXX +2.70%
- X Month XXX +11%
- X Months XXX +111%
- X Year XXX +85%

### CreatorRank: undefined [#](/creator/twitter::1351507242206580736/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1351507242206580736/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1351507242206580736/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [technology brands](/list/technology-brands)  XXXX%

**Social topic influence**
[$novo](/topic/$novo) #10, [$googl](/topic/$googl) 8.33%, [$ampx](/topic/$ampx) 8.33%, [$ntla](/topic/$ntla) 8.33%, [$mdxh](/topic/$mdxh) 8.33%, [$airo](/topic/$airo) 8.33%, [$ossd](/topic/$ossd) 8.33%, [$sgmo](/topic/$sgmo) 8.33%, [$srpt](/topic/$srpt) 8.33%, [$nktr](/topic/$nktr) XXXX%

**Top accounts mentioned or mentioned by**
[@alc2022](/creator/undefined) [@engbl0m](/creator/undefined)

**Top assets mentioned**
[Alphabet Inc Class A (GOOGL)](/topic/$googl) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt)
### Top Social Posts [#](/creator/twitter::1351507242206580736/posts)
---
Top posts by engagements in the last XX hours

"Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress"  
[X Link](https://x.com/Drbagholders/status/1974433910617452873) [@Drbagholders](/creator/x/Drbagholders) 2025-10-04T11:18Z XXX followers, XXX engagements


"💼 $GOOGL Google $AMPX Amprius Technologies $NTLA Intellia Therapeutics $MDXH MDxHealth $AIRO Airo Group $OSSD OssDsign $SGMO Sangamo Therapeutics $SRPT Sarepta Therapeutics $NKTR Nektar Therapeutics $MCLAIR Medclair $NOVO Novo Nordisk $BIOA BioArctic"  
[X Link](https://x.com/Drbagholders/status/1975612700110794883) [@Drbagholders](/creator/x/Drbagholders) 2025-10-07T17:22Z XXX followers, 1306 engagements


"$EMBRAC Embracer Group $ASMODEE Asmodee $ACAST - Acast $HNSA - Hansa Biopharma"  
[X Link](https://x.com/Drbagholders/status/1975614548364406965) [@Drbagholders](/creator/x/Drbagholders) 2025-10-07T17:29Z XXX followers, 1182 engagements


"Omeros Corporation - Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros clinical-stage MASP-3 inhibitor zaltenibart (OMS906) $NOVO $OMER"  
[X Link](https://x.com/Drbagholders/status/1978535133922652179) [@Drbagholders](/creator/x/Drbagholders) 2025-10-15T18:55Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Drbagholders Avatar @Drbagholders DrBagholder

DrBagholder posts on X about $novo, $googl, $ampx, $ntla the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXX -XX%
  • X Month XXXXX +1,371%
  • X Months XXXXXX +23%
  • X Year XXXXXX +1,874%

Mentions: X #

Mentions Line Chart

  • X Week X +14%
  • X Month XX +250%
  • X Months XX +71%
  • X Year XX +529%

Followers: XXX #

Followers Line Chart

  • X Week XXX +2.70%
  • X Month XXX +11%
  • X Months XXX +111%
  • X Year XXX +85%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% technology brands XXXX%

Social topic influence $novo #10, $googl 8.33%, $ampx 8.33%, $ntla 8.33%, $mdxh 8.33%, $airo 8.33%, $ossd 8.33%, $sgmo 8.33%, $srpt 8.33%, $nktr XXXX%

Top accounts mentioned or mentioned by @alc2022 @engbl0m

Top assets mentioned Alphabet Inc Class A (GOOGL) Intellia Therapeutics, Inc (NTLA) Sarepta Therapeutics, Inc. (SRPT)

Top Social Posts #


Top posts by engagements in the last XX hours

"Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress"
X Link @Drbagholders 2025-10-04T11:18Z XXX followers, XXX engagements

"💼 $GOOGL Google $AMPX Amprius Technologies $NTLA Intellia Therapeutics $MDXH MDxHealth $AIRO Airo Group $OSSD OssDsign $SGMO Sangamo Therapeutics $SRPT Sarepta Therapeutics $NKTR Nektar Therapeutics $MCLAIR Medclair $NOVO Novo Nordisk $BIOA BioArctic"
X Link @Drbagholders 2025-10-07T17:22Z XXX followers, 1306 engagements

"$EMBRAC Embracer Group $ASMODEE Asmodee $ACAST - Acast $HNSA - Hansa Biopharma"
X Link @Drbagholders 2025-10-07T17:29Z XXX followers, 1182 engagements

"Omeros Corporation - Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros clinical-stage MASP-3 inhibitor zaltenibart (OMS906) $NOVO $OMER"
X Link @Drbagholders 2025-10-15T18:55Z XXX followers, XXX engagements

@Drbagholders
/creator/twitter::Drbagholders